Theraclion SA (EPA:ALTHE)

Market Cap	30.16M +354.2%
Revenue (ttm)	2.32M +179.3%
Net Income	-5.69M
EPS	n/a
Shares Out	58.01M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	37,580
Average Volume	35,243
Open	0.5200
Previous Close	0.5200
Day's Range	0.4935 - 0.5200
52-Week Range	0.1460 - 1.2500
Beta	0.18
RSI	52.62
Earnings Date	Apr 16, 2026

About Theraclion

Theraclion SA provides therapeutic ultrasound equipment. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient’s skin and optimize image quality. The company was incorporated in 2004 and is headquartered in Malakoff, France.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 31
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALTHE

Financial Performance

In 2025, Theraclion's revenue was 2.32 million, an increase of 179.33% compared to the previous year's 830,209. Losses were -5.69 million, -1.17% less than in 2024.